Connect Sign In
LabMind podcasts
ARUP Laboratories has filed a declaration supporting a lawsuit against the FDA brought by the American Clinical Laboratory Association. |
May 30, 2024 |
ARUP Files Declaration to Support Lawsuit Challenging the FDA's Rule to Regulate Lab-Developed Tests ARUP’s declaration amplifies the lawsuit’s claims that the FDA does not have legal authority over laboratory testing services and that regulating these services is unreasonable. |
Jonathan Genzen, MD, PhD, ARUP’s chief medical officer and senior director of governmental affairs, and Jonathan Carr, JD, chief compliance officer, discuss the FDA’s final rule on LDTs. |
May 28, 2024 |
ARUP Webinar on the FDA’s Final Rule on Laboratory-Developed Tests Now Available ARUP Laboratories is committed to helping clients and the clinical laboratory community navigate regulatory changes and is offering current resources and a new webinar. |
David Shiembob, MBA, C(ASCP)CM, manager of ARUP Healthcare Advisory Services, has received the Clinical Laboratory Scientist Achievement Award from the Association for Diagnostics and Laboratory Medicine (ADLM). |
May 21, 2024 | ARUP Healthcare Advisory Services Manager David Shiembob has received the ADLM Clinical Laboratory Scientist Achievement Award, which recognizes significant contributions to the CLS community. |
Erica Clyde speaks with attendees at BioHive Live. |
May 10, 2024 | The inaugural event created connections among future innovators who look to solve many of healthcare’s biggest challenges. |
|
May 9, 2024 |
Special 40th Anniversary Edition of ARUP’s Magnify Magazine Now Available Online This issue highlights milestones in ARUP’s history, gives a glimpse into the company’s future, and includes a special feature: a video of ARUP founders and current leaders reminiscing and celebrating. |
ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs. |
April 29, 2024 |
ARUP Statement on FDA Final Rule to Regulate Laboratory-Developed Tests as Medical Devices ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat